Compare
Cooper Companies, Inc. vs Bausch & Lomb Corp vs Warby Parker Inc. vs Staar Surgical Co
| Latest fiscal year | Cooper Companies, Inc. COO | Bausch & Lomb Corp BLCO | Warby Parker Inc. WRBY | Staar Surgical Co STAA |
|---|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-31 | 2025-12-31 | 2026-01-02 |
| Revenue | $4.09B | $5.10B | $871.90M | $239.44M |
| Revenue growth (YoY) | +5.1% | +6.5% | +13.0% | -23.7% |
| Gross margin | 65.5% | n/a | 54.0% | 76.2% |
| Operating margin | 16.7% | 2.2% | -0.6% | -38.3% |
| Net margin | 9.2% | -7.1% | 0.2% | -33.6% |
| Net income | $374.90M | -$360.00M | $1.64M | -$80.45M |
| EPS (Diluted) | $1.87 | -$1.02 | $0.01 | -$1.62 |
| Operating cash flow | $796.10M | $283.00M | $110.78M | -$34.23M |
| Free cash flow | $433.70M | -$66.00M | $43.74M | -$40.05M |
| Cash & equivalents | $110.60M | $383.00M | $286.36M | $153.15M |
| Total assets | $12.39B | $14.02B | $720.92M | $451.68M |
| Total liabilities | $4.16B | $7.50B | $353.19M | $107.49M |
| Shareholders' equity | $8.24B | $6.52B | $367.73M | $344.18M |
| Return on year-end equity | 4.6% | -5.5% | 0.4% | -23.4% |
| Shares outstanding | 195.90M | 354.21M | n/a | 49.40M |
Revenue, most recent five fiscal years
| Fiscal year | Cooper Companies, Inc. | Bausch & Lomb Corp | Warby Parker Inc. | Staar Surgical Co |
|---|---|---|---|---|
| Latest | $4.09B Ended 2025-10-31 | $5.10B Ended 2025-12-31 | $871.90M Ended 2025-12-31 | $239.44M Ended 2026-01-02 |
| 1 year earlier | $3.90B Ended 2024-10-31 | $4.79B Ended 2024-12-31 | $771.32M Ended 2024-12-31 | $313.90M Ended 2024-12-27 |
| 2 years earlier | $3.59B Ended 2023-10-31 | $4.15B Ended 2023-12-31 | $669.76M Ended 2023-12-31 | $322.42M Ended 2023-12-29 |
| 3 years earlier | $3.31B Ended 2022-10-31 | $3.77B Ended 2022-12-31 | $598.11M Ended 2022-12-31 | $239.44M Ended 2022-12-30 |
| 4 years earlier | $2.92B Ended 2021-10-31 | $3.77B Ended 2021-12-31 | $540.80M Ended 2021-12-31 | $230.47M Ended 2021-12-31 |